Fusion imaging for parathyroid localization in primary hyperparathyroidism

References

• DeGroot L, Jameson J. Endocrinology. (Ed.). WB Saunders PA, USA (2001).
   Google Scholar
• Lavely WC, Goetze S, Friedman KP et al. Comparison of SPECT/CT, SPECT, and planar imaging with single-and dual-phase (99m)Tc-Sestamibi parathyroid scintigraphy. J. Nucl. Med.48, 1084–1089 (2007).
   PubMed Web of Science ®Google Scholar
• Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol. Head Neck Surg.132, 359–372 (2005).
   PubMed Web of Science ®Google Scholar
• Amar L, Guignat L, Tissier F et al. Video-assisted thoracoscopic surgery as a first-line treatment for mediastinal parathyroid adenomas: strategic value of imaging. Eur. J. Endocrinol.150, 141–147 (2004).
   PubMedGoogle Scholar
• Doppman JL, Skarulis MC, Chen CC et al. Parathyroid adenomas in the aortopulmonary window. Radiology201, 456–462 (1996).
   PubMed Web of Science ®Google Scholar
• Sukumar MS, Komanapalli CB, Cohen JI. Minimally invasive management of the mediastinal parathyroid adenoma. Laryngoscope116, 482–487 (2006).
   PubMedGoogle Scholar
• Kumar A, Kumar S, Aggarwal S, Kumar R, Tandon N. Thoracoscopy: the preferred method for excision of mediastinal parathyroids. Surg. Laparosc. Endosc. Percutan. Tech.12, 295–300 (2002).
   PubMedGoogle Scholar
• Harris B, Bailey D, Roach P, Marshman D, McElduff A, King G. Use of fusion imaging to localize an ectopic thoracic parathyroid adenoma. Ann. Thorac. Surg.82, 719–721 (2006).
   PubMedGoogle Scholar
• Mihai R, Gleeson F, Buley ID, Roskell DE, Sadler GP. Negative imaging studies for primary hyperparathyroidism are unavoidable: correlation of Sestamibi and high-resolution ultrasound scanning with histological analysis in 150 patients. World J. Surg.30, 697–704 (2006).
   PubMed Web of Science ®Google Scholar
• Johnson NA, Tublin ME, Ogilvie JB. Parathyroid imaging: technique and role in the preoperative evaluation of primary hyperparathyroidism. AJR Am. J. Roentgenol.188, 1706–1715 (2007).
   PubMed Web of Science ®Google Scholar
• Bilezikian JP, Khan AA, Potts JT Jr. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J. Clin. Endocrinol. Metab.94, 335–339 (2009).
   PubMed Web of Science ®Google Scholar
• Civelek AC, Ozalp E, Donovan P, Udelsman R. Prospective evaluation of delayed technetium-99m Sestamibi SPECT scintigraphy for preoperative localization of primary hyperparathyroidism. Surgery131, 149–157 (2002).
   PubMed Web of Science ®Google Scholar
• Moka D, Voth E, Dietlein M, Larena-Avellaneda A, Schicha H. Technetium 99m-MIBI-SPECT: a highly sensitive diagnostic tool for localization of parathyroid adenomas. Surgery128, 29–35 (2000).
   PubMedGoogle Scholar
• Siperstein A, Berber E, Mackey R, Alghoul M, Wagner K, Milas M. Prospective evaluation of Sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery136, 872–880 (2004).
   PubMedGoogle Scholar
• Gotway MB, Higgins CB. MR imaging of the thyroid and parathyroid glands. Magn. Reson. Imaging Clin. N. Am.8, 163–182, ix (2000).
   PubMedGoogle Scholar
• McDermott VG, Fernandez RJ, Meakem TJ 3rd, Stolpen AH, Spritzer CE, Gefter WB. Preoperative MR imaging in hyperparathyroidism: results and factors affecting parathyroid detection. AJR Am. J. Roentgenol.166, 705–710 (1996).
   PubMedGoogle Scholar
• Lopez Hanninen E, Vogl TJ, Steinmuller T, Ricke J, Neuhaus P, Felix R. Preoperative contrast-enhanced MRI of the parathyroid glands in hyperparathyroidism. Invest. Radiol.35, 426–430 (2000).
   PubMedGoogle Scholar
• Gotway MB, Reddy GP, Webb WR, Morita ET, Clark OH, Higgins CB. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology218, 783–790 (2001).
   PubMedGoogle Scholar
• Merlino JI, Ko K, Minotti A, McHenry CR. The false negative technetium-99m-Sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am. Surg.69, 225–229 (2003).
   PubMedGoogle Scholar
• Chiu B, Sturgeon C, Angelos P. What is the link between nonlocalizing Sestamibi scans, multigland disease, and persistent hypercalcemia? A study of 401 consecutive patients undergoing parathyroidectomy. Surgery140, 418–422 (2006).
   PubMedGoogle Scholar
• Friedman K, Somervell H, Patel P et al. Effect of calcium channel blockers on the sensitivity of preoperative 99mTc-MIBI SPECT for hyperparathyroidism. Surgery136, 1199–1204 (2004).
   PubMedGoogle Scholar
• Rubello D, Casara D, Fiore D, Muzzio P, Zonzin G, Shapiro B. An ectopic mediastinal parathyroid adenoma accurately located by a single-day imaging protocol of Tc-99m pertechnetate-MIBI subtraction scintigraphy and MIBI-SPECT–computed tomographic image fusion. Clin. Nucl. Med.27, 186–190 (2002).
   PubMedGoogle Scholar
• Ruf J, Lopez Hanninen E, Steinmuller T et al. Preoperative localization of parathyroid glands. Use of MRI, scintigraphy, and image fusion. Nuklearmedizin43, 85–90 (2004).
   PubMedGoogle Scholar
• Profanter C, Prommegger R, Gabriel M et al. Computed axial tomography–MIBI image fusion for preoperative localization in primary hyperparathyroidism. Am. J. Surg.187, 383–387 (2004).
   PubMedGoogle Scholar
• Roach PJ, Schembri GP, Ho Shon IA, Bailey EA, Bailey DL. SPECT/CT imaging using a spiral CT scanner for anatomical localization: impact on diagnostic accuracy and reporter confidence in clinical practice. Nucl. Med. Commun.27, 977–987 (2006).
   PubMedGoogle Scholar
• Profanter C, Wetscher GJ, Gabriel M et al. CT–MIBI image fusion: a new preoperative localization technique for primary, recurrent, and persistent hyperparathyroidism. Surgery135, 157–162 (2004).
   PubMedGoogle Scholar
• Wimmer G, Bale R, Kovacs P et al. Virtual neck exploration in patients with hyperparathyroidism and former cervical operations. Langenbecks Arch. Surg.393, 687–692 (2008).
   PubMedGoogle Scholar
• Ingui CJ, Shah NP, Oates ME. Endocrine neoplasm scintigraphy: added value of fusing SPECT/CT images compared with traditional side-by-side analysis. Clin. Nucl. Med.31, 665–672 (2006).
   PubMedGoogle Scholar
• Even-Sapir E, Keidar Z, Sachs J et al. The new technology of combined transmission and emission tomography in evaluation of endocrine neoplasms. J. Nucl. Med.42, 998–1004 (2001).
   PubMedGoogle Scholar
• Krausz Y, Bettman L, Guralnik L et al. Technetium-99m-MIBI SPECT/CT in primary hyperparathyroidism. World J. Surg.30, 76–83 (2006).
   PubMedGoogle Scholar
• Serra A, Bolasco P, Satta L, Nicolosi A, Uccheddu A, Piga M. Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients. Radiol. Med. (Torino)111, 999–1008 (2006).
   PubMedGoogle Scholar
• Papathanassiou D, Flament JB, Pochart JM et al. SPECT/CT in localization of parathyroid adenoma or hyperplasia in patients with previous neck surgery. Clin. Nucl. Med.33, 394–397 (2008).
   PubMedGoogle Scholar
• Kaczirek K, Prager G, Kienast O et al. Combined transmission and (99m)Tc-Sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin42, 220–223 (2003).
   PubMedGoogle Scholar
• Sharma J, Mazzaglia P, Milas M et al. Radionuclide imaging for hyperparathyroidism (HPT): which is the best technetium-99m Sestamibi modality? Surgery140, 856–863 (2006).
   PubMedGoogle Scholar
• Harris L, Yoo J, Driedger A et al. Accuracy of technetium-99m SPECT-CT hybrid images in predicting the precise intraoperative anatomical location of parathyroid adenomas. Head Neck30, 509–517 (2008).
   PubMedGoogle Scholar
• Neumann DR, Obuchowski NA, Difilippo FP. Preoperative 123I/99mTc-Sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J. Nucl. Med.49, 2012–2017 (2008).
   PubMed Web of Science ®Google Scholar
• Gayed IW, Kim EE, Broussard WF et al. The value of 99mTc-Sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia. J. Nucl. Med.46, 248–252 (2005).
   PubMed Web of Science ®Google Scholar
• Neumann DR, Esselstyn CB Jr, MacIntyre WJ et al. Primary hyperparathyroidism: preoperative parathyroid imaging with regional body FDG PET. Radiology192, 509–512 (1994).
   PubMedGoogle Scholar
• Sundin A, Johansson C, Hellman P et al. PET and parathyroid L-[carbon-11]methionine accumulation in hyperparathyroidism. J. Nucl. Med.37, 1766–1770 (1996).
   PubMed Web of Science ®Google Scholar
• Neumann DR, Esselstyn CB, Maclntyre WJ et al. Comparison of FDG-PET and Sestamibi-SPECT in primary hyperparathyroidism. J. Nucl. Med.37, 1809–1815 (1996).
   PubMed Web of Science ®Google Scholar
• Melon P, Luxen A, Hamoir E, Meurisse M. Fluorine-18-fluorodeoxyglucose positron emission tomography for preoperative parathyroid imaging in primary hyperparathyroidism. Eur. J. Nucl. Med.22, 556–558 (1995).
   PubMedGoogle Scholar
• Otto D, Boerner AR, Hofmann M et al. Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET. Eur. J. Nucl. Med. Mol. Imaging31, 1405–1412 (2004).
   PubMedGoogle Scholar
• Beggs AD, Hain SF. Localization of parathyroid adenomas using 11C-methionine positron emission tomography. Nucl. Med. Commun.26, 133–136 (2005).
   PubMed Web of Science ®Google Scholar
• Hessman O, Stalberg P, Sundin A et al. High success rate of parathyroid reoperation may be achieved with improved localization diagnosis. World J. Surg.32, 774–781 (2008).
   PubMedGoogle Scholar
• Cook GJ, Wong JC, Smellie WJ, Young AE, Maisey MN, Fogelman I. [11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery. Eur. J. Endocrinol.139, 195–197 (1998).
   PubMedGoogle Scholar
• Tang BN, Moreno-Reyes R, Blocklet D et al. Accurate pre-operative localization of pathological parathyroid glands using 11C-methionine PET/CT. Contrast Media Mol. Imaging3, 157–163 (2008).
   PubMedGoogle Scholar
• Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results. World J. Surg.33, 2256–2265 (2009).
   PubMed Web of Science ®Google Scholar
• Terris DJ, Stack BC Jr, Gourin CG. Contemporary parathyroidectomy: exploiting technology. Am. J. Otolaryngol.28, 408–414 (2007).
   PubMedGoogle Scholar
• Chen H, Mack E, Starling JR. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann. Surg.238, 332–337 (2003).
   PubMedGoogle Scholar
• Chen H, Sippel RS, Schaefer S. The effectiveness of radioguided parathyroidectomy in patients with negative technetium tc 99m-Sestamibi scans. Arch. Surg.144, 643–648 (2009).
   PubMedGoogle Scholar
• Grubbs EG, Mittendorf EA, Perrier ND, Lee JE. Gamma probe identification of normal parathyroid glands during central neck surgery can facilitate parathyroid preservation. Am. J. Surg.196, 931–935 (2008).
   PubMedGoogle Scholar
• Norman J, Politz D. 5,000 parathyroid operations without frozen section or PTH assays: measuring individual parathyroid gland hormone production in real time. Ann. Surg. Oncol.16, 656–666 (2009).
   PubMedGoogle Scholar